Metallothionein in Brain Disorders.

Area of Science:

• Neuroscience
• Biochemistry
• Cell Biology

Background:

• Metallothioneins (MTs) are intracellular metal-binding proteins crucial for regulating essential metal metabolism.
• Four major MT isoforms (MT-I to MT-IV) exist, with MT-I, MT-II, and MT-III found in the central nervous system (CNS).
• MT-I and MT-II are primarily in astrocytes, while MT-III is predominantly in neurons within the CNS.

Purpose of the Study:

• To review the current understanding of metallothionein roles in the central nervous system.
• To explore the involvement of MTs in neurodegenerative diseases and other brain disorders.
• To highlight recent evidence on MT functions in neurological contexts.

Main Methods:

• This is a review article, synthesizing existing research and evidence.
• Literature search on metallothioneins, central nervous system, and neurological disorders.
• Analysis of studies investigating MT isoforms, their localization, and functions.

Main Results:

• MT-I and MT-II are implicated in maintaining cellular homeostasis of zinc and copper, heavy metal detoxification, gene regulation, inflammation, and oxidative stress protection.
• MT-III is specifically linked to the pathogenesis of neurodegenerative diseases like Parkinson's and Alzheimer's.
• Evidence suggests MTs participate in various other neurological disorders.

Conclusions:

• Metallothioneins play multifaceted roles in the central nervous system, extending beyond metal homeostasis.
• MT isoforms exhibit distinct functions and localization patterns within the CNS.
• Further research into MTs may offer insights into therapeutic strategies for neurodegenerative and other brain disorders.